Informationen:
Fehler:
Stichworte
Concomitant Medication ×
- Klinische Studie [Dokumenttyp] (16)
- Ophthalmologie (12)
- Klinische Studie, Phase III [Dokumenttyp] (10)
- Therapie (7)
- Parkinsons Disease (5)
- Adverse event (4)
- Diabetes mellitus (4)
- Behandlungsbedürftigkeit, Begutachtung (4)
- Makulaödem (4)
- Anamnesenerhebung (4)
- Pharmakokinetik (3)
- Restless-legs-Syndrom (3)
- Purpura, thrombozytopenische, idiopathische (3)
- Kind (3)
- Neurologie (3)
- Vitalzeichen (2)
- Klinische Labordienstleistungen (2)
- Arzneimitteltherapie (2)
- Makuladegeneration (2)
- Sehen (1)
- Klinische Labortechniken (1)
- Parkinson's Syndrome (1)
- Augenkrankheiten (1)
- Gesundheitszustand (1)
- Leber (1)
- Parkinson-Krankheit (1)
Inhaltsverzeichnis
Ausgewählte Datenmodelle
Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.
22 Suchergebnisse.
Itemgruppen: Date of Visit/ Assessment, Log Status, Concomitant Medications, Non-Serious Adverse Event, Serious Adverse Event - Type of Report, Serious Adverse Event - Randomisation, Serious Adverse Event, Serious Adverse Event - Intensity Changes, Serious Adverse Event - Seriousness, Serious Adverse Event - Relevant Concomitant/ Treatment Medications, Serious Adverse Events - Relevant Medical Conditions/ Risk Factors, Serious Adverse Event - Relevant Diagnostic Results, Serious Adverse Event - Rechallenge, Serious Adverse Event - Investigational Product, Serious Adverse Event - Non clinical
Itemgruppen: Patient administration, CONCOMITANT MEDICATIONS (DAY 0 - MONTH 12), Medication
Itemgruppen: Patient administration, CONCOMITANT MEDICATIONS (DAY 0 - MONTH 12), Medication
Itemgruppen: Patient administration, CONCOMITANT MEDICATIONS (DAY 0 - MONTH 12), Medication
Itemgruppen: Patient administration, CONCOMITANT MEDICATIONS (DAY 0 - MONTH 12), Medication
Itemgruppen: Current Dose Level, Vital signs, Concomitant Medication, Adverse Experiences, L-Dopa Rescue, Study Medication Compliance, End of visit instructions for patients continuing, End of visit instructions for patients not continuing, ERG Examintion Appointment Card, Concomitant Medication, Details on concomitant medication, Levodopa Rescue Therapy, Details on Levodopa - rescue therapy, Adverse Experiences, Details on Adverse Experiences, Investigator´s Signature, Patient Continuation / Withdrawal, Investigator´s Signature
Itemgruppen: General information, Flexible Dose Start Date and Current Dose Level, Vital signs, Concomitant Medication, Adverse Experiences, Study Medication Compliance, Concomitant medication, Details of Concomitant Medication, Levodopa rescue, Details of Ledopa Rescue Therapy, Adverse Experiences, Details on adverse experiences, Patient Continuation/Withdrawal
Itemgruppen: Concomitant Medication Information, Concomitant Medication, Adverse Experiences, Adverse Experience Details, Investigator´s Signature
Itemgruppen: Vital signs, Concomitant medication, Adverse Experiences, Study Medication Compliance, Patient continuation
Itemgruppen: Screening Baseline Conclusion, Investigator´s signature
Itemgruppen: General Information, Informed Consent, Demography, Vital signs, Date of onset of symptoms of parkinson´s disease, Modified Hoehn and Yahr Parkinsons Disease Staging, Significant medical / surgical history and physical examination, Details on Significant medical or surgical condition, Prior anti-parkinson medication, Details on prior anti-parkinson medication, Other prior medication (excluding anti-parkinson medication), Details on other prior medication (excluding anti-parkinson medication), Inclusion Criteria, Exclusion Criteria, Laboratory tests
Logs and Repeats (Logs/Rpts) Pazopanib Macular Degeneration MD1103367 - Logs and Repeats (Logs/Rpts)
Itemgruppen: Date of visit, Adverse Event; concomitant medication; questions